pharma · Analgesia · Postoperative Pain · HRTX
Heron Therapeutics
Heron Therapeutics clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 100 Regency Forest Dr, Cary, North Carolina 27518, US
- Founded
- 1983
- Employees
- 188
- Programs
- 18
- Drugs
- 17
- Patents
- 46
Heron Therapeutics projects
7 ClinicalTrials.gov programs sponsored by Heron Therapeutics.
Heron Therapeutics has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Bupivacaine HCl
Heron Therapeutics
Analgesia
1 trial -
Bupivacaine Hydrochloride
Heron Therapeutics
Analgesia
1 trial -
Bupivacaine liposome injectable suspension
Heron Therapeutics
Analgesia
1 trial -
HTX-011
Heron Therapeutics
Analgesia
6 trials -
HTX-011
Heron Therapeutics
Postoperative Pain
8 trials -
SUSTOL
Heron Therapeutics
Chemotherapy-Induced Nausea and Vomiting (CINV)
1 trial -
ZYNRELEF 200Mg-6Mg Extended-Release Solution
Heron Therapeutics
Post Operative Pain, Acute
1 trial
Frequently asked questions
How many clinical projects does Heron Therapeutics have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.